Primary ILM peeling prevents macula pucker development

Article

Primary peeling of the internal limiting membrane (ILM) successfully prevents the development of macula pucker and the full removal of all epiretinal membranes.

Primary peeling of the internal limiting membrane (ILM) successfully prevents the development of macula pucker and the full removal of all epiretinal membranes, claims a study in the journal Retina.

The investigation, led by Dr D. Odrobina, Klinika Okulistyczna, Poland, included of 84 patients who underwent retinectomy with silicone oil tamponade for retinal detachment caused by proliferative vitreoretinopathy.

Eyes were split into two groups with 33 eyes in group A and 51 eyes in group B. In group A the ILM was peeled and in group B the ILM was not peeled. The effect of ILM peeling for the prevention of macula pucker was determined by slit-lamp examination.

The first month after retinectomy revealed cases of extramacular epiretinal cellular proliferation in 3 eyes in group A and 3 eyes in group B. In the final follow-up there were no macular pucker cases in group A and 9 cases of macula pucker in group B.

Eyes with retinal detachment caused by proliferative vitreoretinopathy were successfully treated by retinectomy and silicone oil tamponade. Primary peeling of the ILM is a successful method of preventing the development of macula pucker.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.